DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Rule 64B3-3.001
December 12, 2018

Please click here to read more information regarding the recent changes to the “General Requirements of Clinical Laboratory Personnel Training Programs.” Continue reading


Dental Sedation Workshop
December 11, 2018

Click here for more information about the Dental Sedation Workshop that will take place on February 14, 2019. Continue reading